## New Norwell's first annual loss in 2025.
The annual profit card of 2025 million yuan was issued on the evening of 16 March, and the company achieved business income of 2,158 million yuan a year, an increase of 8.93 per cent; however, the net profit earned by the mother amounted to $241 million, resulting in a net loss of $294 million. This is the first annual loss since the landing of New Novak ' s share in 2019, with the expansion of the biographical scale only at about 900 million yuan. Before 2024, the company had achieved a net profit of more than $700 million from the net profits of the parent ' s business income for two consecutive years, representing a significant contrast to the large loss of profits; the firm had clearly marked the decline in its base of $241 million from coffee and health-based food products, which was the key source of the shift from traditional raw materials to innovation.
---
- **Source**: 新诺威（石药创新制药）
- **Sector**: The Vault
- **Tags**: 新诺威（石药创新制药）, 财报亏损, 创新药转型, 巨石生物, 研发投入, 比特币挖矿
- **Credibility**: unverified
- **Published**: 2026-03-28 16:25:57
- **ID**: 39158
- **URL**: https://whisperx.ai/en/intel/39158